[1]
Chou KC. An insightful 10-year recollection since the emergence of the 5-steps rule. Curr Pharm Des 2019; 25(40): 4223-34.
[2]
Dong Y, Qu X, Wu G, et al. Advances in the detection, mechanism and therapy studies of chronic kidney disease. Curr Pharm Des 2019; 25(40): 4235-50.
[3]
Zhang Y, Liu Z. Oncolytic virotherapy for malignant tumor: current clinical status. Curr Pharm Des 2019; 25(40): 4251-63.
[4]
Zhou G, Zhao M, Liang R, et al. Study of mechanism on binding between neratinib and MAD2L1 based on molecule simulation and multi-spectroscopy methods. Curr Pharm Des 2019; 25(40): 4287-95.
[5]
Zhang D, Guan Z-X, Zhang Z-M, et al. Recent development of computational predicting bioluminescent proteins. Curr Pharm Des 2019; 25(40): 4264-73.
Current Pharmaceutical Design
Title:Advancement of Technology for Precision Medicine
Volume: 25 Issue: 40
Author(s): Bing Niu
Affiliation:
Export Options
About this article
Cite this article as:
Niu Bing , Advancement of Technology for Precision Medicine, Current Pharmaceutical Design 2019; 25 (40) . https://dx.doi.org/10.2174/138161282540191230093056
DOI https://dx.doi.org/10.2174/138161282540191230093056 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
11
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Somatostatin and its Analogs
Current Drug Targets Trabectedin (Yondelis®) as a Therapeutic Option in Gynecological Cancers: A Focus on its Mechanisms of Action, Clinical Activity and Genomic Predictors of Drug Response
Current Drug Targets Recent Advances in the Research and Development of B-Raf Inhibitors
Current Medicinal Chemistry Hypoxic Regulation of Metastasis via Hypoxia-Inducible Factors
Current Molecular Medicine Stability Analysis at Key Positions of EGFR Related to Non-small Cell Lung Cancer
Current Bioinformatics Dendrimers and the Development of New Complex Nanomaterials for Biomedical Applications
Current Medicinal Chemistry EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination?
Current Genomics Tumor Control by Manipulation of the Human Anti-Apoptotic Survivin Gene
Current Cancer Therapy Reviews Preclinical Development of Novel Anti-Glioma Drugs Targeting the Endoplasmic Reticulum Stress Response
Current Pharmaceutical Design Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site
Anti-Cancer Agents in Medicinal Chemistry Berberine as a Promising Safe Anti-Cancer Agent- Is there a Role for Mitochondria?
Current Drug Targets The Epidemiological, Mechanistic and Potential Clinical Role of Androgen Receptor (AR) in Urothelial Carcinoma
Current Drug Targets Current Strategies to Overcome Resistance to ALK-Inhibitor Agents
Current Drug Metabolism Spongiane Diterpenoids
Current Bioactive Compounds Mitigative Effects of a Combination of Multiple Pharmaceutical Drugs on the Survival of Mice Exposed to Lethal Ionizing Radiation
Current Pharmaceutical Biotechnology Malignant Mesothelioma Resistance to Apoptosis: Recent Discoveries and their Implication for Effective Therapeutic Strategies
Current Medicinal Chemistry In Utero Gene Therapy: Prospect and Future
Current Pharmaceutical Design Editorial (Hot Topic: Synthetic, Natural and Related Compounds: New Approach to Chronic Diseases Studies)
Current Topics in Medicinal Chemistry Selective Cyclooxygenase-2 Inhibitors and Non-small Cell Lung Cancer
Current Medicinal Chemistry Patent Selections:
Recent Patents on Biomarkers